Loading…
Resgen (BSE 543805)₹46.50+1.09%Refineries & Marketing
In the Mar 2026 quarter (consolidated), Resgen reported sales of ₹32.89 Cr, down 15.4% from Mar 2025, and net profit of ₹5.99 Cr, up 50.1% year on year. For the year to Mar 2026, sales were ₹70.77 Cr and net profit ₹9.98 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|
| Sales | 38.87 | 37.89 | 32.89 |
| Expenses | 31.09 | 31.08 | 26.08 |
| Operating Profit | 8.03 | 7.02 | 7.03 |
| OPM % | 20.0% | 18.0% | 19.9% |
| Other Income | 0.00 | 0.00 | 1.99 |
| Interest | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.99 | 0.99 | 0.99 |
| Profit before tax | 5.99 | 4.99 | 6.99 |
| Tax % | 31.0% | 22.1% | 32.1% |
| Net Profit | 3.99 | 3.99 | 5.99 |
| EPS (Rs) | 1.98 | 1.93 | 2.95 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 64.78 | 70.77 |
| Expenses | 50.15 | 58.18 |
| Operating Profit | 15.05 | 14.06 |
| OPM % | 24.0% | 18.9% |
| Other Income | 0.00 | 1.99 |
| Interest | 0.99 | 0.00 |
| Depreciation | 3.99 | 2.99 |
| Profit before tax | 10.98 | 11.98 |
| Tax % | 28.0% | 28.1% |
| Net Profit | 7.99 | 9.98 |
| EPS (Rs) | 3.81 | 4.87 |
| Dividend payout % | 0.0% | 0.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 21.01 | 20.98 |
| Reserves | 37.14 | 47.15 |
| Borrowings | 5.02 | 1.01 |
| Other Liabilities | 8.03 | 6.03 |
| Total Liabilities | 71.20 | 75.17 |
| Fixed Assets | 17.01 | 15.03 |
| CWIP | 0.00 | 0.00 |
| Investments | 0.00 | 4.99 |
| Other Assets | 54.19 | 55.15 |
| Inventories | 23.91 | 24.08 |
| Trade receivables | 19.86 | 25.19 |
| Cash & equivalents | 1.81 | 2.20 |
| Total Assets | 71.20 | 75.17 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from operating activity | 7.01 | 3.99 |
| Cash from investing activity | −1.01 | 0.00 |
| Cash from financing activity | −4.98 | −2.99 |
| Net cash flow | 1.99 | 0.00 |
| Capex | 1.59 | 0.36 |
| Free cash flow | 6.02 | 4.01 |
| CFO / OP % | 70.9% | 57.9% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor days | 112 | 130 |
| Inventory days | 180 | 159 |
| Days payable | 21 | 14 |
| Cash conversion cycle | 271 | 275 |
| Working capital days | 198 | 221 |
| ROCE % | — | 19.0% |
For the Mar 2026 quarter, Resgen reported sales of ₹32.89 Cr, down 15.4% year on year and net profit of ₹5.99 Cr, up 50.1% year on year. The operating margin was 19.9%.
Resgen's sales for the year to Mar 2026 were ₹70.77 Cr.
Net profit for the year to Mar 2026 was ₹9.98 Cr. Earnings per share over the same trailing period were ₹4.87.
Resgen reported borrowings of ₹1.01 Cr at Mar 2026, against cash and equivalents of ₹2.20 Cr.
Cash from operations was ₹3.99 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹4.01 Cr.